Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-043420
Filing Date
2010-03-01
Accepted
2010-02-26 21:50:43
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ENDO PHARMACEUTICALS HOLDINGS INC. d10k.htm 10-K 2276454
2 AMENDED AND RESTATED BY-LAWS OF ENDO dex32.htm EX-3.2 78999
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 2126
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2289
5 POWER OF ATTORNEY dex24.htm EX-24 10204
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6313
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6316
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3758
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3747
10 GRAPHIC g86158g32t06.jpg GRAPHIC 59648
  Complete submission text file 0001193125-10-043420.txt   2473933
Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address 100 ENDO BOULEVARD CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Filer) CIK: 0001100962 (see all company filings)

EIN.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15989 | Film No.: 10641793
SIC: 2834 Pharmaceutical Preparations